13 commercial payer policies list J9601. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
13 policies from 10 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J9601 |
|---|---|---|
| linvoseltamab-gcpt (Lynozyfic) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Linvoseltamab-gcpt (Lynozyfic) | Not recorded | Covered with conditionsInferred from policy title |
| Policy | Effective | Status of J9601 |
|---|---|---|
| linvoseltamab-gcpt (Lynozyfic) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Linvoseltamab-gcpt (Lynozyfic) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9601 |
|---|---|---|
| Lynozyfic (linvoseltamab-gcpt) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Lynozyfic (linvoseltamab-gcpt) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9601 |
|---|---|---|
| Linvoseltamab-gcpt (e.g., Lynozyfic) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9601 |
|---|---|---|
| LYNOZYFIC (LINVOSELTAMAB-GCPT) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9601 |
|---|---|---|
| Linvoseltamab-gcpt (Lynozyfic) | Dec 31, 2025 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9601 |
|---|---|---|
| Cigna MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of J9601 |
|---|---|---|
| Linvoseltamab-gcpt (Lynozyfic); CP.PHAR.743 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9601 |
|---|---|---|
| Q3 - 2026 Jefferson Health Plans MedOnc Master Drug List | Not recorded | Prior auth required |
| Policy | Effective | Status of J9601 |
|---|---|---|
| Lynozyfic (linvoseltamab-gcpt) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |